Apollo Pipes Ltd

- Apollo Pipes plans a total capex of INR 500 crores over the next 3-4 years. - INR 100 crores allocated for ongoing expansions: Dadri-1 brownfield and Dadri-2 greenfield projects. - INR 400 crores earmarked for three new greenfield plants, including land costs. - Greenfield plants to be set up across West, South, and East India to reduce reliance on North market. - Capacity expansion aims to double capacity to 286,000 metric tons in 3-4 years. - First contribution from greenfield projects expected within 15 months, targeting Q1 FY 2025. - Equity infusion commitment of INR 260 crores booked as funding for part of capex. - Annual investment expected around INR 150-200 crores, funded through equity and operating cash flows. - Strategic objective is geographical expansion, focusing on value-added products like CPVC and bath fittings.

- The company plans an equity infusion of INR 260 crores to fund its capex requirements. - This equity infusion commitment is already in place, with funds available "as and when the need comes." - The equity infusion is in the form of warrants, allowing flexibility on the timing of the funds. - Total planned capex is INR 500 crores over 3-4 years, with INR 100 crores for ongoing expansions and INR 400 crores for three new greenfield plants (including land). - Capex funding will come from this equity infusion and operating cash flows, with no mention of new debt fundraising for these expansions.

- Apollo Pipes targets a **35% revenue CAGR over the next 4 years**, aiming to utilize expanded capacity of 286,000 tons. - For FY '24, the company expects around **25% revenue growth**, viewing it as a focus year within the longer-term 35% CAGR guidance. - Volume growth is expected at about **28% to 30%**, driven by ramping up existing and new product lines including CPVC, solvent weld fittings, water storage tanks, bath fittings, and new PPR products. - Apollo plans to expand geographically beyond North India into West, South, and East with new plants sized around 30,000 to 35,000 tons, gaining new market share. - Growth will come from capturing incremental industry expansion of INR3,500-4,000 crores annually and gaining share from both organized Tier 1/2 companies and unorganized players. - The company expects EBITDA per ton margins of 16%-17% during this hyper-growth phase, supported by improved sales mix and value-added products.

- Apollo Pipes targets a 35% revenue CAGR over the next 4 years, leveraging capacity expansion to 286,000 tons. - EBITDA per ton guidance is INR16 to INR17 for the next 2-3 years, with gradual improvement to INR18-19 once new plants stabilize. - Gross profit per ton and gross margins are expected to improve steadily, driven by higher-value products like CPVC and bath fittings. - Initial capex and fixed costs will weigh on margins during hyper-growth but are expected to lead to better profitability long-term. - Aggressive market expansion across new geographies will support volume growth and market share gains, contributing to earnings growth. - Ad spends will increase to about 1.75%-2.25% of sales to fuel growth, indicating strategic investment in brand visibility and market penetration. - Working capital efficiency is expected to improve with geographic expansion and localized production facilities, aiding cash flow and margins.

The transcript on the provided pages does not explicitly mention the current or expected order book or pending orders for Apollo Pipes Limited. However, some insights related to capacity utilization and expansion plans indicate demand dynamics: - Operating capacity utilization expected to reach 70% by first half of FY '25 on current 136,000 tons capacity. - Additional capacity of 25,000 tons being added to cover FY '21 demand. - New greenfield projects expected to start contributing from Q1 FY '25 (within 15 months). - Expansion aimed at increasing market share, particularly in CPVC and value-added product segments. - Company confident of replicating market share gains from North India in new geographies through capacity expansion. No direct quantitative order book value or pending order details were provided in the transcript excerpt.